Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese Price Caps: Industry Aims For New Product Payment Group Inclusion

This article was originally published in The Gray Sheet

Executive Summary

Changes to Japan's C1 and C2 new product payment categories will create incentives for foreign firms to launch products in the country, AdvaMed maintains

You may also be interested in...



Global Challenges In 2003: Japanese Pricing, EU Reclassifications

European regulatory authorities are on the verge of upclassifying several surgically invasive device categories, despite fervent Eucomed-led opposition mounted during 2003

Global Challenges In 2003: Japanese Pricing, EU Reclassifications

European regulatory authorities are on the verge of upclassifying several surgically invasive device categories, despite fervent Eucomed-led opposition mounted during 2003

Legislators Urge Japan Trade Acquiescence; Industry Lobbies Health Ministry

AdvaMed Exec VP-Global Strategy & Analysis Marjory Searing will testify at a formal meeting of Japanese Ministry of Health, Labor & Welfare officials Nov. 20 as part of the association's increased efforts to resolve longstanding objections to Japan's regulatory and reimbursement policies

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019194

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel